Trials / Completed
CompletedNCT00332059
Safety and Efficacy Study of Bimatoprost/Timolol Fixed Combination in Patients With Glaucoma or Ocular Hypertension
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 445 (actual)
- Sponsor
- Allergan · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to assess the safety and efficacy of Bimatoprost/Timolol Fixed Combination in patients with glaucoma or ocular hypertension
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | bimatoprost/timolol fixed combination |
Timeline
- Start date
- 2003-05-01
- Primary completion
- 2004-09-01
- Completion
- 2004-09-01
- First posted
- 2006-06-01
- Last updated
- 2011-05-30
Locations
4 sites across 4 countries: United States, Austria, Canada, Germany
Source: ClinicalTrials.gov record NCT00332059. Inclusion in this directory is not an endorsement.